Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2025-03-13 Regulatory Filings
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 13 March 2025, informing stock exchanges (BSE and NSE) about a scheduled meeting with an analyst/investor on March 27, 2025. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an upcoming investor meeting rather than a detailed report or transcript. It does not contain financial data, management discussion, or any detailed presentation materials. Given the short length (2150 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about an investor meeting schedule, not a full investor presentation or report.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 13 March 2025, addressed to stock exchanges, informing about the schedule of a meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an upcoming investor meeting, not a report or transcript of the meeting itself. It does not contain financial data, results, or detailed presentations. The length is only 1971 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled meeting with analysts/investors. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an event rather than a detailed report or transcript. It is only 2128 characters long and does not contain financial data, management discussion, or any detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 13 March 2025, informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of a meeting schedule rather than a financial report or detailed presentation. It does not contain financial data, results, or detailed disclosures. The length is only 2137 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2157 characters) informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of a meeting schedule rather than a detailed investor presentation or financial report. It does not contain financial data, analysis, or detailed presentation materials. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit into other specific categories.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the schedule of a meeting with an analyst/investor. It explicitly states that no new presentation will be made and that the company does not intend to discuss any unpublished price sensitive information. The document is short (2144 characters) and serves as an announcement of an upcoming event rather than a report or detailed financial disclosure. It does not contain financial data, management discussion, or regulatory filings beyond the meeting notice. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-03-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.